Connect with your Account executive. Fill out the form below to get in touch with your dedicated myriad account executive.

* Required field

Hidden Fields











Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Clarify cancer treatment with Precise™ Oncology Solutions

Through one ordering process, Precise Oncology Solutions can uncover the answers you need to optimize your patients’ treatment plans.

Multiple genetic tests, one seamless experience

Checklist icon

One platform

Precise Oncology Solutions combines germline and somatic testing onto one platform to help you and your staff save time, and get faster answers for your patients.

DNA icon

Clear results

Test results arrive quickly, with an easy-to-interpret summary sheet to help you clarify your treatment decisions.

A robust suite of germline and somatic tests

Your Precise Oncology Solutions order can include up to 4 key genetic tests to help you determine your patients’ treatment options.

Precise Oncology Solutions
Germline
BRACAnalysis CDx®

(FDA-Approved)

MyRisk™

(Non-FDA-Approved)

HRD* Status
MyChoice®CDx

(FDA-Approved)

Tumor Profiling
MyChoice®CDx

(FDA-Approved)

Tumor profiling
Precise™ Tumor

(Non-FDA-Approved)

* For patients with ovarian cancer.
† Precise™ Tumor is powered by Intermountain Precision Genomics, a service of Intermountain® Healthcare.

Get the answers you need, every step of the way

Precise Oncology Solutions provides genetic testing options to support your patients’ care, regardless of where they are in their treatment journeys. The accurate genetic insights from our tests can help you choose the appropriate surgical technique or type of chemotherapy, identify patients who may qualify for clinical trials, aid your network of colleagues as they assess patients for additional care, and more.

Join us for the Myriad Genetics Monthly Molecular Tumor Board

Each month, we convene with clinical experts to review patient cases and discuss leading edge treatment strategies.

Topics of discussion may include:

  • Targeted therapy options based on genomic data
  • Prior lines of treatment and their impact on additional lines of therapy
  • Potential hereditary implications of genomic findings

Visit Myriad Live to learn more

This is not a CME event.

Connect with your Account executive. Fill out the form below to get in touch with your dedicated myriad account executive.